Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 1/2017

01-01-2017 | Letter to the Editor

Care Transitions Measure and Readmissions

Authors: Amanda S. Mixon, MD, MS, MSPH, FHM, Sunil Kripalani, MD, MSc, SFHM

Published in: Journal of General Internal Medicine | Issue 1/2017

Login to get access

Excerpt

To the Editor: We echo the concerns explicated in Goldstein et al.’s recent article regarding the inconsistent association between the Care Transitions Measure (CTM-3) and readmission risk.1 Their findings add to the mounting evidence questioning the predictive ability of the CTM-3 and its use as a quality indicator of care transitions. …
Literature
1.
Goldstein JN, Hicks LS, Kolm P, Weintraub WS, Elliott DJ. Is the Care Transitions Measure associated with readmission risk? Analysis from a single academic center. J Gen Intern Med. 2016;31(7):732–8.CrossRefPubMedPubMedCentral
2.
Mixon AS, Goggins K, Bell SP, Vasilevskis EE, Nwosu S, Schildcrout JS, Kripalani S. Preparedness for hospital discharge and prediction of readmission. J Hosp Med. 2016. doi:10.​1002/​jhm.​2572.
3.
Atreya AR, Pack QR. Care Transition Measure score and coronary revascularization related readmission: ready for primetime use? J Gen Intern Med. 2016;31(7):707–9.CrossRefPubMedPubMedCentral
4.
Kansagara D, Englander H, Salanitro A, Kagen D, Theobald C, Freeman M, Kripalani S. Risk prediction models for hospital readmission: a systematic review. JAMA. 2011;306(15):1688–1698.CrossRefPubMedPubMedCentral
5.
Meyers AG, Salanitro A, Wallston KA, Cawthon C, Vasilevskis EE, Goggins KM, Davis CM, Rothman RL L, Castel LD, Donato KM, Schnelle JF, Bell SP, Schildcrout JS, Osborn CY, Harrell FE, Kripalani S. Determinants of health after hospital discharge: rationale and design of the Vanderbilt Inpatient Cohort Study (VICS). BMC Health Serv Res. 2014;14:10.CrossRefPubMedPubMedCentral
Metadata
Title
Care Transitions Measure and Readmissions
Authors
Amanda S. Mixon, MD, MS, MSPH, FHM
Sunil Kripalani, MD, MSc, SFHM
Publication date
01-01-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3867-z

Other articles of this Issue 1/2017

Journal of General Internal Medicine 1/2017 Go to the issue

Review Paper

Recommendations for Providers on Person-Centered Approaches to Assess and Improve Medication Adherence

Healing Arts: Materia Medica

Stained

Original Research

Vital Signs Are Still Vital: Instability on Discharge and the Risk of Post-Discharge Adverse Outcomes

Editorial

Lessons from the Rise—and Fall?—of VA Healthcare

Editorial

Acting with Restraint

Capsule Commentary

Capsule Commentary on Blackstock et al., A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption among Primary Care Physicians
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits